Correction: Bonaccorso et al. Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application. Pharmaceutics 2020, 12, 476
Angela Bonaccorso, Maria Rosa Gigliobianco, Rosalia Pellitteri, Debora Santonocito, Claudia Carbone, Piera Di Martino, Giovanni Puglisi, Teresa Musumeci
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCurcumin's Biomedical Applications · Biochemical effects in animals · Natural product bioactivities and synthesis
In the original publication [1], there was a mistake in Figure 5 as published. The mistake was related to the samples “mann” and “p.m. curc-mann-P188”. For the sample Mann, an image of low quality was erroneously inserted, and now, in Figure 5, all the acquisitions made, even those with better quality, are given for completeness. For the other sample (P.m. Curc-Mann-188), additional magnifications are provided for better clarity of the sample analyzed because for samples already inserted with the same magnification, there were effects on image quality due to hygroscopic sample conductivity. The corrected Figure 5 and legend appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bonaccorso A. Gigliobianco M.R. Pellitteri R. Santonocito D. Carbone C. Di Martino P. Puglisi G. Musumeci T. Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application Pharmaceutics 20201247610.3390/pharmaceutics 1205047632456163 PMC 7284456 · doi ↗ · pubmed ↗